Increase of Nexstim Plc's share capital with subscriptions

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Increase of Nexstim Plc's share capital with subscriptions based on stock options 2010A, 2011A and 2013A

 

Company announcement, Helsinki, 26 May 2016, at 9:00 a.m.

Nexstim Plc (NXTMH: HEX, NXTMS: STO) is a medical technology company aiming to improve rehabilitation for stroke patients with the use of non-invasive brain stimulation. The company announces the subscription of 106,075 new shares in Nexstim Plc based on stock options 2010A, 2011A and 2013A. The corresponding increase in the company's share capital, i.e. EUR 1,060.75 to be credited to the company's invested unrestricted equity, will be registered in the Trade Register on or around 30 May 2016. Trading in the new shares registered at this time will commence on the Nasdaq First North Finland and Nasdaq First North Sweden on or around 1 June 2016. The right to dividends and other rights conferred by shares will come into effect when the increase in share capital has been registered in the Trade Register. Nexstim Plc holds a total of 72.268 stock options under the stock option plans 2010A and 2013A. The remaining outstanding stock options 2010A and 2013A provide entitlement to subscribe for a maximum of 608.597 shares for EUR 0.01 per share. The share subscription period for stock option 2010A ends on 31 December 2016 and for stock option 2013A on 31 December 2020. Nexstim Plc's share capital will be EUR 80,000 after the increase.

NEXSTIM PLC Martin Jamieson, CEO

Further information is available on the website www.nexstim.com or by contacting:

Nexstim                                                                                                                                  Martin Jamieson, CEO                                                                                     +447715163942                                                                                                 martin.jamieson@nexstim.com

UB Securities Oy (Certified Adviser)                                                          +358 (0)9 2538 0246

Consilium Strategic Communications                                                        +44 (0)20 3709 5700 Mary-Jane Elliott / Ivar Milligan / Laura Thornton                     nexstim@consilium-comms.com

About Nexstim Plc Nexstim is a medical technology company aiming to improve rehabilitation for stroke patients. Nexstim has pioneered its technology as a diagnostic tool for brain surgery with its Navigated Brain Stimulation (NBS) system. It is the first and only FDA cleared and CE-marked system based on the navigated transcranial magnetic stimulation (nTMS) for pre-surgical mapping of the speech and motor cortices of the brain. Based on the same technology platform, the company has developed a device called Navigated Brain Therapy (NBT®) for use in the rehabilitation of stroke patients. Nexstim shares are listed on the Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com

 

HUG#2015571

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Faces Class Action: Compliance Claims Tested

Updated Category News Views 25

An Unfolding Legal Drama for Gildan Alright, folks, it's time to dissect what's going on with Gildan Activewear, where things have taken a hard left turn into legal chaos. A class action lawsuit is shaking up the table, and let me tell you, it's got more layers than an onion. The case hinges on allegations that the company pulled a fast one with its financial controls,...

Continue Reading
Ampace Showcases Safety-First Battery Tech for AI Data Centers

Updated Category News Views 80

PU200's Debut: Making Safety and Space Work in Tandem Ever noticed how safety's become the name of the game for data center operations? Powered by the influx of AI, these digital fortresses crave robust power backup, and Ampace’s stepping in with their PU200 UPS battery solution at Data Centre World Paris 2026. Showing off at Hall 5, Booth M65, Ampace's bringing to the...

Continue Reading
Maritime Symposium Fuels Youth's Ocean Governance Aspirations

Updated Category News Views 81

Maritime Seminar Sparks Global Engagement Kicking things off, Sanya played host to a side event of the 7th Symposium on Global Maritime Cooperation and Ocean Governance, reminding everyone that the sea isn't just about waves and tides — it's a political arena too. Discussions floated around like a choppy ocean current, with more than 10 international voices weighing in....

Continue Reading
AAKP Champions Veterans' Kidney Health Initiatives

Updated Category News Views 109

Honor Through Health: AAKP's Commitment Veterans Day 2026 is a bittersweet reminder of services and sacrifices made. Enter the American Association of Kidney Patients (AAKP), the seasoned player taking Veterans' health initiatives into the limelight like an old standby pitcher braving one more inning. Their Veterans Health Initiative (VHI) isn't just a token effort—it's...

Continue Reading
AI Adoption Institute Targets ROI with Peer Circles

Updated Category News Views 73

Transforming AI from Cost to Profit Alright folks, we all know AI's the flashy tool everyone's jumping on like it's the latest tech bandwagon. But here’s the raw deal: most of these shiny AI investments ain't paying back a damn thing. Enter the AI Adoption Institute (AiAi)—a new player in Denver aiming to salvage this mess and make AI about actual returns. Peering...

Continue Reading
Group 1 Automotive Expands with Lexus Gwinnett Acquisition

Updated Category News Views 19

Unifying the Landscape: Group 1's Bold Move with Lexus Gwinnett Another piece of the puzzle drops into place as Group 1 Automotive continues its aggressive campaign to unify its dealership network. The latest acquisition sees the Hennessy Lexus of Gwinnett rebranded as Lexus Gwinnett, adding another notch to their belt in the bustling Atlanta-market corridor. Group 1's...

Continue Reading
International Tower Hill's Q3 Results: Gold Updates

Updated Category News Views 90

An Eye on International Tower Hill's Latest Moves You've got International Tower Hill Mines (TSX: ITH, NYSE American: THM) laying their cards on the table for the third quarter. This ain't just any routine check-in—it's a glimpse at their Livengood Gold Project, standing tall on the promise of gold beyond the horizon. A cool $106 million in cash? Not too shabby, folks....

Continue Reading
Elisa and Sensofusion Launch Joint Drone Venture in Europe

Updated Category News Views 56

A Match Made Beneath the Clouds Woke up today thinking about the bizarre world of drones, and it looks like Elisa Corporation and Sensofusion Plc are paving a new path in the skies of Europe. The two firms have locked hands to form Masthead Oy, aimed at creating a bird’s-eye defense mechanism to manage the unruly swarm of drones buzzing around Finland and Estonia. The...

Continue Reading
Terra-Gen's $950M Lockhart Facility Powers California

Updated Category News Views 75

A New Giant in California's Solar Landscape Out in California's desert, Terra-Gen has flipped the switch on something pretty colossal: the $950 million Lockhart Solar and Storage Project. Picture this—a solar beast boasting 538.7 MW of capacity, primed to light up around 350,000 homes and businesses. That's not just flipping a light switch; that's sparking a fire that...

Continue Reading
Align's Innovative Transporter Revolutionizes Engine Assembly

Updated Category News Views 84

Align's Game-Changer in Engine Manufacturing Let's face it, the world of heavy-duty equipment isn't always filled with breakthroughs. But every once in a while, a game-changer rolls off the line, and that's what's happening with Align Production Systems. They've crafted a custom omnidirectional transporter that does more than just move bulky engine assemblies; it...

Continue Reading

Top 5 Most Recently Viewed Articles

Alterity Therapeutics Accelerates Development of ATH434 Drug

Updated Category News Views 225

Overview of ATH434 and Fast Track Designation Alterity Therapeutics, a leading biotechnology company dedicated to developing treatments for neurodegenerative conditions, has made significant strides with its candidate, ATH434. The U.S. FDA has recently granted Fast Track designation, marking a pivotal moment in advancing the treatment of Multiple System Atrophy (MSA)....

Continue Reading
WuXi Biologics Achieves GMP Certification for Quality Assurance

Updated Category News Views 245

WuXi Biologics Earns GMP Certification for Facilities WuXi Biologics, a prominent player in the Contract Research, Development, and Manufacturing Organization (CRDMO) sector, proudly shared news of its recent achievement: the successful GMP certification of three of its cutting-edge manufacturing facilities. This certification, awarded by Türkiye ?laç ve T?bbi Cihaz...

Continue Reading
Wirex Limited Names Chet Shah CEO to Accelerate Innovation

Updated Category News Views 282

Wirex Limited Welcomes Chet Shah as New CEO Wirex Limited, a leading regulated payments platform based in the UK, has recently named Chet Shah as its new Chief Executive Officer. Chet has been a vital part of the team for the past three transformative years, serving as the Chief Risk & Compliance Officer. His vast experience and dedication played a crucial role in...

Continue Reading
KOORUI to Launch Groundbreaking 750Hz Monitor at CES 2025

Updated Category News Views 178

KOORUI to Launch Groundbreaking 750Hz Monitor at CES 2025 As a leader in the display industry, KOORUI is preparing to showcase its latest innovations at CES 2025. Attendees will have the chance to visit KOORUI at Booth #35609 in South Hall 2 of the Las Vegas Convention Center and experience firsthand the cutting-edge technology that defines the future of displays....

Continue Reading
Iris Energy Limited Faces Securities Investigation Over Claims

Updated Category News Views 88

Iris Energy Limited Under Investigation for Class Action Claims The Rosen Law Firm, a well-known advocate for investor rights, has launched an investigation into potential securities claims that could impact shareholders of Iris Energy Limited (NASDAQ: IREN). This inquiry comes in light of serious allegations that Iris Energy may have provided misleading information about...

Continue Reading